Nanoparticles Kills Cancer Cells | Nanotechnology Future Cancer Treatment Technique

Nanoparticles to recognize, attack cancer cells

7:20 AM, 16th August 2013
University of Georgia Research News
Shanta Dhar, Assistant Professor, University of Georgia.

GEORGIA, US: Researchers at the University of Georgia are developing a new treatment technique that uses nanoparticles to reprogramme immune cells so they are able to recognize and attack cancer. The findings were published recently in the early online edition of ACS Nano. The human body operates under a constant state of martial law. Chief among the enforcers charged with maintaining order is the immune system, a complex network that seeks out and destroys the hordes of invading bacteria and viruses that threaten the organic society as it goes about its work.

The immune system is good at its job, but it’s not perfect. Most cancerous cells, for example, are able to avoid detection by the immune system because they so closely resemble normal cells, leaving the cancerous cells free to multiply and grow into life-threatening tumors while the body’s only protectors remain unaware. Shanta Dhar, Assistant Professor, University of Georgia and her colleagues are giving the immune system a boost through their research.

“What we are working on is specifically geared toward breast cancer. Our paper reports for the first time that we can stimulate the immune system against breast cancer cells using mitochondria-targeted nanoparticles and light using a novel pathway,” said Dhar.

In their experiments, Dhar and her colleagues exposed cancer cells in a petri dish to specially designed nanoparticles 1,000 times finer than the width of a human hair. The nanoparticles invaded the cell and penetrated the mitochondria - the organelles responsible for producing the energy a cell needs to grow and replicate.

They then activated the nanoparticles inside the cancer cells by exposing them to a tissue-penetrating long wavelength laser light. Once activated, the nanoparticles disrupt the cancer cell’s normal processes, eventually leading to its death. The dead cancer cells were collected and exposed to dendritic cells, one of the core components of the human immune system. What the researchers saw was remarkable.

“We are able to potentially overcome some of the traditional drawbacks to today’s dendritic cell immunotherapy. By targeting nanoparticles to the mitochondria of cancer cells and exposing dendritic cells to these activated cancer cells, we found that the dendritic cells produced a high concentration of chemical signals that they normally don’t produce, and these signals have traditionally been integral to producing effective immune stimulation,” said Sean Marrache, Graduate Student.

“The dendritic cells recognized the cancer as something foreign and began to produce high levels of interferon-gamma, which alerts the rest of the immune system to a foreign presence and signals it to attack. We basically used the cancer against itself,” added Dhar.

She cautions that the results are preliminary, and the approach works only with certain forms of breast cancer. But if researchers can refine the process, this technology may one day serve as the foundation for a new cancer vaccine used to both prevent and treat disease. “We particularly hope this technique could help patients with advanced metastatic disease that has spread to other parts of the body,” said Dhar.

If the process were to become a treatment, doctors could biopsy a tumor from the patient and kill the cancerous cells with nanoparticles. They could then produce activated dendritic cells in bulk quantities in the lab under controlled conditions before the cells were injected into the patient. Once in the bloodstream, the newly activated cells would alert the immune system to the cancer’s presence and destroy it.

“These are the things we can now do with nanotechnology. If we can refine the process further, we may be able to use similar techniques against other forms of cancer as well,” said Dhar.

© University of Georgia News

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


Elemental Minerals gets potash mining license in Republic of Congo

PERTH, AUSTRALIA: Elemental Minerals Ltd has been awarded a mining license for its Sintoukola Potash project in the Republic of Congo (RoC). The award ...

Read more
Evonik expands oil additives plant in Singapore

ESSEN, GERMANY: Evonik Industries will significantly expand its Jurong Island, Singapore oil additives plant. The expansion is expected to be complete ...

Read more
GranBio, Rhodia to build bio n-butanol facility in Brazil

SAO PAULO, BRAZIL: Brazilian biotechnology company, GranBio, and Rhodia, a Solvay Group company, have signed an agreement to create a partnership to p ...

Read more
Invista, SilicoLife to develop bio-derived processes for industrial chemicals

WICHITA, US/GUIMARAES, PORTUGAL: SilicoLife, computational biology company, and Invista will collaborate for the development of new technologies to en ...

Read more
Technip bags NCRA’s hydrogen plant contract in Kansas, US

PARIS, FRANCE: Technip, in consortium with its construction partner Performance Contractors Inc, was awarded a contract by the National Cooperative Re ...

Read more
Sudarshan Chemicals wins appeal in European court against Clariant

MUMBAI, INDIA: Sudarshan Chemical Industries, Global producer of performance colourants and effect pigments, has won an appeal in a European court aga ...

Read more